Bloomberg's Madison Muller and Amanda Mull break down a rising black-market trend in the 'wellness' space, as customers look for more shots to fix issues like sleep or weight following the success of GLP-1s. However, Muller says that the drugs carry a risk, whether it's using a non FDA tested substance or user error around the injection itself. (Source: Bloomberg)
Bloomberg's Madison Muller and Amanda Mull break down a rising black-market trend in the 'wellness' space, as customers look for more shots to fix issues like sleep or weight following the success of GLP-1s. However, Muller says that the drugs carry a risk, whether it's using a non FDA tested substance or user error around the injection itself. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/38fbbc1d89bf04c8e34e325b6c061437bbcd7b7a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Black-Market Peptides Fuel a Multibillion-Dollar Gold Rush"></iframe>
